Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725282 | SCV000335681 | uncertain significance | not provided | 2017-06-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725282 | SCV000525243 | benign | not provided | 2019-08-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000374998 | SCV000612533 | benign | not specified | 2016-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083052 | SCV000656754 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002338835 | SCV002619085 | benign | Inborn genetic diseases | 2019-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |